![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1348453
¼¼°èÀÇ ÁÖÀÔ ÆßÇÁ ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(2024-2030³â) - MedCoreInfusion Pump Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore | Includes: Large-Volume Infusion Pumps, Syringe Infusion Pumps, and 3 more |
2023³â ¼¼°èÀÇ ÁÖÀÔ ÆßÇÁ ½ÃÀå ±Ô¸ð´Â 35¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î º¸À̸ç, 34¾ï ´Þ·¯¿´´ø Àü³âº¸´Ù 3.1% Áõ°¡Çß½À´Ï´Ù. ÀÌ ½ÃÀåÀº ¿¹Ãø±â°£ µ¿¾È¿¡µµ CAGR 2.6%·Î °è¼Ó ¼ºÀåÇÏ°í ±Ã±ØÀûÀ¸·Î 42¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¼¼°èÀÇ ÁÖÀÔ ÆßÇÁ ½ÃÀåÀÇ ÇöÀç »óȲÀº Becton Dickinson(BD)°ú B. BraunÀÇ µÎ ÁÖ¿ä ¾÷üÀÇ Á¸Àç¿¡ ÀÇÇØ ÁÖ·Î ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ÁÖÀÔ ÆßÇÁ ½ÃÀåÀº ¿©·¯ ¿äÀο¡ ÈûÀÔ¾î »ó½Â¼¼¸¦ Ÿ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼ºÀå¿¡ Å©°Ô ±â¿©ÇÑ ¿äÀÎÀº ³ëÀÎ Àα¸ÀÇ Áõ°¡·Î ÀÎÇØ ÀÇ·á ºÐ¾ß¿¡¼ ÁÖÀÔ ÆßÇÁ¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô¾ÆÁ³´Ù´Â Á¡ÀÔ´Ï´Ù. ³ëÀεéÀÌ º¹ÀâÇÑ ¾à¹° ¿ä¹ý¿¡ Á¡Á¡ ´õ ÀÇÁ¸ÇÔ¿¡ µû¶ó ÁÖÀÔ ÆßÇÁ´Â ÀǾàǰÀÇ Á¤È®ÇÏ°í ¾ÈÀüÇÑ Àü´ÞÀ» º¸ÀåÇÏ´Â µ¥ ÇʼöÀûÀÎ µµ±¸·Î ºÎ»óÇß½À´Ï´Ù.
»ïŰ±â ¾î·Æ°Å³ª ¼¼½ÉÇÑ ¿ë·® °ü¸®°¡ ÇÊ¿äÇÑ ³ëÀΠȯÀÚµéÀº ÁÖÀÔ ÆßÇÁ¸¦ ÅëÇØ ¾à¹°À» Á¤¹ÐÇÏ°Ô Á¦¾îÇÏ¿© Åõ¿©ÇÔÀ¸·Î½á »ó´çÇÑ ÀÌÁ¡À» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù. ³ëÀÎ Àα¸°¡ °è¼Ó Áõ°¡ÇÔ¿¡ µû¶ó ƯÁ¤ ¾à¹° ¿ä°ÇÀ» ÃæÁ·ÇÏ´Â µ¥ ÀÖ¾î ÁÖÀÔ ÆßÇÁÀÇ Á߿伺Àº ¿©ÀüÈ÷ Áß¿äÇϸç ÀÇ·á Áö¿ø¿¡¼ Á¡Á¡ ´õ Áß¿äÇÑ ¿ªÇÒÀ» ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
2023³â¿¡´Â Becton Dickinson(BD)Àº Àü ¼¼°è ÁÖÀÔ ÆßÇÁ ½ÃÀå¿¡¼ È®½ÇÇÑ ¸®´õ·Î ºÎ»óÇß½À´Ï´Ù. BD´Â CareFusionÀ» Àü·«ÀûÀ¸·Î ÀμöÇÏ¿© ±¤¹üÀ§ÇÑ Á¤¸ÆÁÖ»ç Ä¡·á Á¦Ç° ¶óÀΰú °áÇÕÇÔÀ¸·Î½á Á¤¸ÆÁÖ»ç ÆßÇÁ ºÎ¹®¿¡¼ È®°íÇÑ Áö¹è·ÂÀ» È®¸³Çß½À´Ï´Ù. ƯÈ÷ BDÀÇ Alaris¢ç Á¦Ç° ¶óÀÎÀº Alaris¢â PC À¯´Ö, Alaris¢â ÆßÇÁ ¸ðµâ, Alaris¢â ½Ã¸°Áö ¸ðµâ, Alaris¢â PCA ¸ðµâ, Alaris¢â Auto-ID ¸ðµâ, Alaris¢â EtCO2¿Í °°Àº ÇÙ½É ¸ðµâÀ» Æ÷ÇÔÇÏ´Â ¸ðµâÇü ½Ã½ºÅÛÀ¸·Î ´Ù¾çÇÑ ÀÇ·á ȯ°æ¿¡ ¸Â´Â Á¾ÇÕ ¼Ö·ç¼ÇÀ» Á¦°øÇÑ´Ù´Â Á¡¿¡¼ Â÷º°¼ºÀ» °®½À´Ï´Ù.
B. BraunÀº 2023³â ±Û·Î¹ú ÀÎÇ»Àü ÆßÇÁ ½ÃÀå¿¡¼ 2À§¸¦ Â÷ÁöÇÏ¸ç ±× µÚ¸¦ ¹Ù¦ ÂѰí ÀÖ½À´Ï´Ù. ÀÌ È¸»ç´Â ¼ÒÇÁÆ®¿þ¾î °³¼±°ú °ø°£ È¿À²ÀûÀÎ ¼³°è¿¡ ƯÈ÷ ÁßÁ¡À» µÎ°í ÀÎÇ»Àü ÆßÇÁ Á¦Ç° ¶óÀÎÀ» °ÈÇÏ´Â µî Çõ½Å¿¡ ´ëÇÑ °·ÂÇÑ ÀÇÁö¸¦ º¸¿©ÁÖ¾ú½À´Ï´Ù. ¼¼°èÀûÀ¸·Î ÀÎÁ¤¹Þ´Â ¼Ö·ç¼ÇÀÎ B. BraunÀÇ Infusomat¢ç üÀû ÆßÇÁ´Â ¿À·£ ±â°£ µ¿¾È »ç¿ëµÇ¾î ¿ÔÀ¸¸ç, ÃֽйöÀüÀÎ Infusomat¢ç ½ºÆäÀ̽º´Â Ưº°È÷ ¾ð±ÞÇÒ °¡Ä¡°¡ ÀÖ½À´Ï´Ù. ÀÌ ÀÛ°í °¡º¿î ÀåÄ¡´Â ½×À» ¼ö ÀÖµµ·Ï ¼³°èµÇ¾î °ø°£ Ȱ¿ëµµ¸¦ ÃÖÀûÈÇϰí Á¦ÇÑµÈ °ø°£¿¡ ¿©·¯ ´ëÀÇ ÆßÇÁ¸¦ È¿À²ÀûÀ¸·Î ¹èÄ¡ÇÒ ¼ö ÀÖ½À´Ï´Ù.
¼¼°èÀÇ ÁÖÀÔ ÆßÇÁ(Infusion Pump) ½ÃÀå¿¡ ´ëÇØ Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä/ºÎ¹®º° µ¿Çâ/½ÃÀå ºÐ¼® ¹× ÇâÈÄ ¿¹Ãø µî Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
In 2023, the worldwide infusion pump market boasted a total worth of $3.5 billion, marking a 3.1% uptick from the previous year when it stood at $3.4 billion. Projections indicate a continued growth trajectory throughout the forecast period, with a compound annual growth rate (CAGR) of 2.6%, ultimately reaching an estimated value of $4.2 billion. Notably, the current landscape of the global infusion pump market is predominantly influenced by the presence of two key players, namely Becton Dickinson (BD) and B. Braun.
Our extensive medical market research efforts encompassed a comprehensive evaluation of more than 25 infusion pump companies spanning across all seven continents. Employing a rigorous methodology, we delved into various facets of the market, including market sizes, unit sales, company market shares, and generated precise forecasts. The complete report suite dedicated to the global infusion pump market encompasses a range of categories, including large-volume infusion pumps, syringe infusion pumps, patient-controlled analgesia (PCA) infusion pumps, electronic ambulatory infusion pumps, and disposable ambulatory infusion pumps.
The global infusion pump market is on an upward trajectory, driven by several factors. A significant contributor to this growth is the increasing elderly population, which has heightened the demand for infusion pumps in the realm of healthcare. As older individuals increasingly rely on complex medication regimens, infusion pumps have emerged as indispensable tools for ensuring the precise and safe delivery of pharmaceuticals.
Senior patients, who may face challenges such as difficulty swallowing or the need for meticulous dosage management, derive substantial benefits from the precise and controlled administration of medications facilitated by infusion pumps. As the demographic of elderly individuals continues to expand, the significance of infusion pumps in meeting their specific medication requirements remains paramount and is expected to play an increasingly critical role in healthcare assistance.
In the year 2023, Becton Dickinson (BD) emerged as the undisputed leader in the global infusion pump market. BD's strategic acquisition of CareFusion, coupled with its extensive IV therapy product line, firmly established its dominance in the IV infusion pump sector. Notably, BD's Alaris® product line distinguishes itself as a modular system encompassing vital modules such as the Alaris™ PC Unit, Alaris™ Pump Module, Alaris™ Syringe Module, Alaris™ PCA Module, Alaris™ Auto-ID Module, and Alaris™ EtCO2, providing comprehensive solutions tailored for diverse healthcare settings.
Close on its heels, B. Braun secured the second position in the global infusion pump market for the year 2023. The company showcased a strong commitment to innovation, enhancing its infusion pump product lines with a particular emphasis on software improvements and space-efficient designs. B. Braun's Infusomat® volumetric pump, a globally recognized solution, has been available for a significant duration, and its latest iteration, the Infusomat® Space, deserves special mention. This compact and lightweight device is designed for stackability, optimizing space utilization and enabling the efficient placement of multiple pumps in limited areas.
The remainder of the market share was distributed among various competitors, each focusing on specific segments, with only a handful competing across the entire spectrum. Companies like BD and B. Braun enjoy a distinctive advantage in this market due to their ability to offer a diverse range of infusion pumps, serving as comprehensive one-stop solutions for healthcare facilities seeking to expand their pump capabilities.